Ann: Appendix 4C - quarterly, page-6

The revenue for this quarter was still 1.7m. They just didn’t receive the whole amount in cash yet. About $400k in receivables more than likely.

I was pretty bullish on the company update today. UK proceeding well, all MOU’s in place apart from Medtl. The non-performance may have required them to have facilities in place for patch/Prizma that medtl did not come through on.

USA provider agreements are a nice surprise and tell me the sales people are doing their jobs. IDTF increasing (1.3 last qtr and 1.7 this quarter) nicely and I expect them to continue increasing.

Hygea deferment was a surprise but in fairness falls within the agreement terms and timeframes.

Yes CFDA again delayed. I too am frustrated with this. I must of missed the part where yacov or whoever said it was due last year or within a short period of time because CFDA has always been a long process for any group (even Brendan at the AGM said it usually takes 3 years)... and yes we have green channel but that’s only new and from my understanding only accelerates a short part of the process. The cynic in me says that maybe something unfortunate happened to the PI guy allowing some Chinese groups to build up their shareholdings... all my speculation of course.

We’ve waited 2 years. What’s another 3 months considering yacov is backing this until next June 2020 (almost another year... which cdfa is guaranteed to be within I presume as it will be 3 years)

I continue to hold and accumulate where I can. Nothing but weak buying pressure causing this to fall sharply. The ASX has always been terrible at valuing things though. They mostly based on what the financial review tells them.

My calcs.
Est total revenue this year
Q1 - 1.3m
Q2 - 1.7m
Q3- 2.1m
Q4-2.5m

Total - 7.6m
X8 multiple / 398m SOI= 15c/share
X10 multiple / 398m SOI =19c/share
X15 multiple /398m SOI =29c/share
X20 multiple / 398 SOI =38c/share

The above is not unrealistic and I only based it on the IDTF facilities. Considering a large portion of the SOI’s are yacovs which are unlikely to sell this only increases the fair value of the shares. I agree with others that there will be no additional CR due to NASDAQ/HKSE listings and yacovs backing.

Tomorrow might get ugly and yes some people get impatient or want out. But lots of things are happening in the background and there’s always fresh money floating around looking for an entry point.

I will say that over the past few weeks though a lot of people appear to have been inclined to take everything the company says as fiction and what they dont say as fact. I can’t really argue against this either way but I still believe in the story.

This is coming from someone who bought in the 50’s